Glen Eagle Advisors’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-124
| Closed | -$26.9K | – | 1070 |
|
|
2021
Q1 | $26.9K | Sell |
124
-36
| -23% | -$7.81K | 0.01% | 459 |
|
|
2020
Q4 | $18.5K | Hold |
160
| – | – | 0.01% | 512 |
|
|
2020
Q3 | $15.6K | Buy |
160
+36
| +29% | +$3.51K | 0.01% | 508 |
|
|
2020
Q2 | $15.2K | Buy |
+124
| New | +$15.2K | 0.01% | 486 |
|
|
2018
Q2 | – | Sell |
-60
| Closed | -$6.76K | – | 711 |
|
|
2018
Q1 | $6.76K | Hold |
60
| – | – | 0.01% | 490 |
|
|
2017
Q4 | $7.92K | Hold |
60
| – | – | 0.01% | 465 |
|
|
2017
Q3 | $6.09K | Sell |
60
-60
| -50% | -$6.09K | 0.01% | 494 |
|
|
2017
Q2 | $12K | Buy |
120
+5
| +4% | +$501 | 0.01% | 367 |
|
|
2017
Q1 | $13.9K | Buy |
115
+90
| +360% | +$10.9K | 0.01% | 330 |
|
|
2016
Q4 | $2.79K | Buy |
+25
| New | +$2.79K | ﹤0.01% | 480 |
|